Related Experiment Video
Updated: Nov 30, 2025

12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.9K
Progress Toward Regional Measles Elimination - Worldwide, 2000-2019
MMWR. Morbidity and Mortality Weekly Report
|November 12, 2020
Summary
Global measles control efforts show progress in reducing deaths but face challenges. Increased vaccination coverage and improved surveillance are crucial for achieving elimination goals.
Area of Science:
- Public Health
- Epidemiology
- Vaccinology
Background:
- World Health Assembly set measles control milestones for 2015, including vaccination coverage and incidence reduction.
- Global Vaccine Action Plan aimed for measles elimination in five WHO regions by 2020.
- Progress in measles control and elimination efforts from 2000-2019 is assessed.
Purpose of the Study:
- To evaluate progress towards World Health Assembly measles control milestones.
- To assess the status of regional measles elimination objectives.
- To identify challenges and recommend strategies for future measles control.
Main Methods:
- Analysis of global measles vaccination coverage data (MCV1).
- Review of measles surveillance sensitivity indicators.
- Examination of global measles incidence and mortality trends.
- Assessment of measles deaths averted through interventions.
Main Results:
- Routine measles-containing vaccine first dose (MCV1) coverage plateaued at 84%-85% after increasing from 72% in 2000.
- Measles surveillance sensitivity targets were not met by approximately half of all countries.
- Annual reported measles incidence decreased significantly by 2016 but rose by 2019.
- Estimated measles deaths decreased by 62% between 2000 and 2019, averting 25.5 million deaths.
Conclusions:
- While significant progress has been made in reducing measles mortality, global measles elimination targets remain challenging.
- Stagnating vaccination coverage and surveillance gaps hinder progress.
- Additional strategies are needed to reach unvaccinated children, close immunity gaps, and enhance surveillance systems.
Related Concept Videos
Vaccinations
49.7K
Overview
49.7K
Principles of Disease Surveillance
351
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
351
Microorganisms in Medicine and Therapeutics
710
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
710
Prevalence and Incidence
1.2K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.2K
Transmission-based Precautions II: Airborne and Protective Environment
1.7K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.7K

